Here's Yet Another Reason to Buy Viking Therapeutics Stock Like There's No Tomorrow
In fact, Viking just gave investors an update which firms up its status as a very promising company. Here's what it reported, ...
Amgen's experimental jab causes 20 per cent weight loss in early results
Amgen's experimental weight loss injection, MariTide, showed up to 20% weight loss in patients without diabetes and 17% in ...
Wegovy is a weight-loss drug. Health Canada says it can now be used to curb heart-attack risk
Canada's health regulator has approved Novo Nordisk's weight-loss drug Wegovy to reduce the risk of nonfatal heart attack or ...
GlobalData on MSN7h
Health Canada approves Novo Nordisk’s Wegovy to cut heart attacks
Health Canada has approved Novo Nordisk’s semaglutide injection, Wegovy, marking it as the first treatment in the country ...
European pharma’s growth prescription: pivot to US
The biggest threat for European pharmaceutical groups currently comes from the United States. President-elect Donald Trump ...
Scandasia.com16h
Novo Nordisk expands footprint in China with recruitment shift
Novo Nordisk shifts its recruitment focus to China, expanding operations to meet rising demand for Ozempic and Wegovy in the ...
The Guardian Nigeria17h
Don raises alarm as diabetes cases surge, may rise to 783m by 2045
Diabetologist and Consultant Endocrinologist at the College of Medicine, University of Lagos and Lagos University Teaching Hospital, ...
healthday22h
American Heart Association, Nov. 16-18
The annual meeting of the American Heart Association was held this year from Nov. 16 to 18 in Chicago, drawing attendees from around the world, includ ...